CA1289883C - Compose therapeutique topique contenant un systeme inhibiteur de l'oxydation - Google Patents

Compose therapeutique topique contenant un systeme inhibiteur de l'oxydation

Info

Publication number
CA1289883C
CA1289883C CA000502248A CA502248A CA1289883C CA 1289883 C CA1289883 C CA 1289883C CA 000502248 A CA000502248 A CA 000502248A CA 502248 A CA502248 A CA 502248A CA 1289883 C CA1289883 C CA 1289883C
Authority
CA
Canada
Prior art keywords
interferon
therapeutic composition
water soluble
moieties
soluble polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000502248A
Other languages
English (en)
Inventor
Eva A. Terpinski
Douglas Testa
Sean A. Evans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Interferon Sciences Inc
Original Assignee
Interferon Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/697,320 external-priority patent/US4710376A/en
Application filed by Interferon Sciences Inc filed Critical Interferon Sciences Inc
Priority to CA000502248A priority Critical patent/CA1289883C/fr
Application granted granted Critical
Publication of CA1289883C publication Critical patent/CA1289883C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA000502248A 1985-02-01 1986-02-19 Compose therapeutique topique contenant un systeme inhibiteur de l'oxydation Expired - Fee Related CA1289883C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000502248A CA1289883C (fr) 1985-02-01 1986-02-19 Compose therapeutique topique contenant un systeme inhibiteur de l'oxydation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/697,320 US4710376A (en) 1985-02-01 1985-02-01 Topical therapeutic composition containing oxidation inhibitor system
CA000502248A CA1289883C (fr) 1985-02-01 1986-02-19 Compose therapeutique topique contenant un systeme inhibiteur de l'oxydation

Publications (1)

Publication Number Publication Date
CA1289883C true CA1289883C (fr) 1991-10-01

Family

ID=25670913

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000502248A Expired - Fee Related CA1289883C (fr) 1985-02-01 1986-02-19 Compose therapeutique topique contenant un systeme inhibiteur de l'oxydation

Country Status (1)

Country Link
CA (1) CA1289883C (fr)

Similar Documents

Publication Publication Date Title
US4680175A (en) Interferon administration vehicles
US4929442A (en) Compositions suitable for human topical application including a growth factor and/or related materials
US4847079A (en) Biologically stable interferon compositions comprising thimerosal
US5773581A (en) Conjugate of a solution stable G-CSF derivative and a water-soluble polymer
US5236707A (en) Stabilization of human interferon
HUT75533A (en) Improved interferon polymer conjugates
UA79430C2 (en) Method for the stepwise attachment of polyethylene glycol to polypeptide
JPS60243028A (ja) インタ−フエロンの可溶化方法
IL109403A0 (en) Oral drug delivery compositions and methods
HUT71586A (en) Process for producing lyp0philized polyalkyene oxide modified protein and polypeptide complexes with cyclodextrin
HU227992B1 (en) Interferon conjugates, process for prepairing them, pharmaceutical compositions, containing them and use of them
EP0247860A2 (fr) Formulation du facteur de nécrose de tumeurs et sa préparation
JPH10506912A (ja) 安定な、水性αインターフェロン溶液処方物
JPH05503090A (ja) 非グリコシル化ｆｇｆ―４およびそれを含む組成物
EP0364491A1 (fr) Formulations stabilisees d'interferons gamma
RU94046426A (ru) Фармацевтические композиции, способы лечения лейкоза, способ повышения уровней стволовых клеток, антагонист с - kit - лиганда, антисмысловая нуклеиновая кислота, способ лечения меланомы, способ усиления трансфекции, способ переноса гена, способ увеличения уровней периферической крови, способ повышения уровней тромбоцитов, способы модификации биологической функции, способ лечения анемии, способ улучшения приживления костного мозга, способ ускорения восстановления костного мозга, способ лечения лейкопении
HU228877B1 (en) Formulations for stabilization of peg-interferon alpha conjugates and method for preparation such formulations
CN103923209B (zh) 一种Lambda干扰素突变体及聚乙二醇衍生物
US4710376A (en) Topical therapeutic composition containing oxidation inhibitor system
IE63842B1 (en) Substitution analogues of magainin peptides
CA1289883C (fr) Compose therapeutique topique contenant un systeme inhibiteur de l'oxydation
KR100351495B1 (ko) α-인터페론BDBB를포함하는수성액상제제
JP2009502779A (ja) 生体適合性ポリマーに結合させたヒト成長ホルモン
CN105085658A (zh) 一种白细胞介素29突变体及聚乙二醇衍生物
AU662940B2 (en) Stabilized pharmaceutical composition of non-glycosylated recombinant human IL2 in reduced form and its preparation process

Legal Events

Date Code Title Description
MKLA Lapsed